A new study, published in The Lancet Infectious Diseases journal, provides the first ever reliable data on antibiotic use in non-European Union (EU) southern and eastern European countries and newly independent states.
Mar 19, 2014
0
0
Using aspirin urgently could substantially reduce the risk of major strokes in patients who have minor 'warning' events, a group of European researchers has found. Writing in the Lancet, the team say that immediate self-treatment ...
May 18, 2016
0
242
(Medical Xpress) -- Controversy exists over how many embryos should be implanted during assisted conception (in-vitro fertilisation/IVF) therapy. New research by the University of Bristol and published in the The Lancet shows ...
Jan 12, 2012
0
0
.jpg)
A drug which 'reboots' a person's immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a 'first-line' ...
Oct 31, 2012
0
0
Scientists at the Wellcome Trust Sanger Institute and their collaborators have discovered genetic markers in malaria parasites linked with resistance to the anti-malarial drug piperaquine. Reported in Lancet Infectious Diseases, ...
Nov 3, 2016
0
21
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published ...
Aug 8, 2012
0
0
Treating "brain tsunamis” or "killer waves” could stop many victims of major head injury from suffering additional brain damage, a study published in Lancet Neurology has found.
Dec 7, 2011
0
0
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network (ITN), ...
Aug 27, 2013
0
0
According to Anna R. Giuliano, Ph.D., program leader in cancer epidemiology at Moffitt Cancer Center in Tampa, Fla., and colleagues in the Netherlands, earlier circumcision of males in South Africa may be a positive step ...
Oct 6, 2011
3
0
Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...
Jun 18, 2021
0
3
